Selected research
Market Structure
Global Embolization Microsphere Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Embolization Microsphere market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Embolization Microsphere is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Embolization Microsphere is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Embolization Microsphere is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Embolization Microsphere is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Embolization Microsphere include Terumo Corporation, Cook Medical, Boston Scientific, Sirtex Medical, Merit Medical, INterface BIOmaterials B.V., HENGRUI Medical and BTG Medical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Embolization Microsphere market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Embolization Microsphere and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Embolization Microsphere sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Embolization Microsphere market size, projected growth trends, production technologies, key applications, and end-use industries.
Embolization Microsphere Segment by Company
Terumo Corporation
Cook Medical
Boston Scientific
Sirtex Medical
Merit Medical
INterface BIOmaterials B.V.
HENGRUI Medical
BTG Medical
Embolization Microsphere Segment by Type
8ml Syringe
3ml Syringe
2ml Syringe
Other
Embolization Microsphere Segment by Application
Uterine Fibroid Embolization
Prostatic Artery Embolization
Liver Tumor Embolization
Trauma Embolization
Other
Embolization Microsphere Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Embolization Microsphere market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Embolization Microsphere and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Embolization Microsphere.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Embolization Microsphere market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Embolization Microsphere manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Embolization Microsphere in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Embolization Microsphere in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- 8ml Syringe
- 3ml Syringe
- 2ml Syringe
- Other
Applications
- Uterine Fibroid Embolization
- Prostatic Artery Embolization
- Liver Tumor Embolization
- Trauma Embolization
- Other
Companies covered
- Terumo Corporation
- Cook Medical
- Boston Scientific
- Sirtex Medical
- Merit Medical
- INterface BIOmaterials B.V.
- HENGRUI Medical
- BTG Medical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Embolization Microsphere Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Embolization Microsphere Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Embolization Microsphere Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Embolization Microsphere Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Embolization Microsphere Market Dynamics
- 2.1 Embolization Microsphere Industry Trends
- 2.2 Embolization Microsphere Industry Drivers
- 2.3 Embolization Microsphere Industry Opportunities and Challenges
- 2.4 Embolization Microsphere Industry Restraints
3 Embolization Microsphere Market by Manufacturers
- 3.1 Global Embolization Microsphere Revenue by Manufacturers (2021-2026)
- 3.2 Global Embolization Microsphere Sales by Manufacturers (2021-2026)
- 3.3 Global Embolization Microsphere Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Embolization Microsphere Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Embolization Microsphere Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Embolization Microsphere Manufacturers, Product Type & Application
- 3.7 Global Embolization Microsphere Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Embolization Microsphere Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Embolization Microsphere Players Market Share by Revenue in 2025
- 3.8.3 2025 Embolization Microsphere Tier 1, Tier 2, and Tier 3
4 Embolization Microsphere Market by Type
- 4.1 Embolization Microsphere Type Introduction
- 4.1.1 8ml Syringe
- 4.1.2 3ml Syringe
- 4.1.3 2ml Syringe
- 4.1.4 Other
- 4.2 Global Embolization Microsphere Sales by Type
- 4.2.1 Global Embolization Microsphere Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Embolization Microsphere Sales by Type (2021-2032)
- 4.2.3 Global Embolization Microsphere Sales Market Share by Type (2021-2032)
- 4.3 Global Embolization Microsphere Revenue by Type
- 4.3.1 Global Embolization Microsphere Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Embolization Microsphere Revenue by Type (2021-2032)
- 4.3.3 Global Embolization Microsphere Revenue Market Share by Type (2021-2032)
5 Embolization Microsphere Market by Application
- 5.1 Embolization Microsphere Application Introduction
- 5.1.1 Uterine Fibroid Embolization
- 5.1.2 Prostatic Artery Embolization
- 5.1.3 Liver Tumor Embolization
- 5.1.4 Trauma Embolization
- 5.1.5 Other
- 5.2 Global Embolization Microsphere Sales by Application
- 5.2.1 Global Embolization Microsphere Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Embolization Microsphere Sales by Application (2021-2032)
- 5.2.3 Global Embolization Microsphere Sales Market Share by Application (2021-2032)
- 5.3 Global Embolization Microsphere Revenue by Application
- 5.3.1 Global Embolization Microsphere Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Embolization Microsphere Revenue by Application (2021-2032)
- 5.3.3 Global Embolization Microsphere Revenue Market Share by Application (2021-2032)
6 Global Embolization Microsphere Sales by Region
- 6.1 Global Embolization Microsphere Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Embolization Microsphere Sales by Region (2021-2032)
- 6.2.1 Global Embolization Microsphere Sales by Region (2021-2026)
- 6.2.2 Global Embolization Microsphere Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Embolization Microsphere Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Embolization Microsphere Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Embolization Microsphere Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Embolization Microsphere Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Embolization Microsphere Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Embolization Microsphere Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Embolization Microsphere Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Embolization Microsphere Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Embolization Microsphere Revenue by Region
- 7.1 Global Embolization Microsphere Revenue by Region
- 7.1.1 Global Embolization Microsphere Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Embolization Microsphere Revenue by Region (2021-2026)
- 7.1.3 Global Embolization Microsphere Revenue by Region (2027-2032)
- 7.1.4 Global Embolization Microsphere Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Embolization Microsphere Revenue (2021-2032)
- 7.2.2 North America Embolization Microsphere Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Embolization Microsphere Revenue (2021-2032)
- 7.3.2 Europe Embolization Microsphere Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Embolization Microsphere Revenue (2021-2032)
- 7.4.2 Asia-Pacific Embolization Microsphere Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Embolization Microsphere Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Embolization Microsphere Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Terumo Corporation
- 8.1.1 Terumo Corporation Company Information
- 8.1.2 Terumo Corporation Business Overview
- 8.1.3 Terumo Corporation Embolization Microsphere Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Terumo Corporation Embolization Microsphere Product Portfolio
- 8.1.5 Terumo Corporation Recent Developments
- 8.2 Cook Medical
- 8.2.1 Cook Medical Company Information
- 8.2.2 Cook Medical Business Overview
- 8.2.3 Cook Medical Embolization Microsphere Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Cook Medical Embolization Microsphere Product Portfolio
- 8.2.5 Cook Medical Recent Developments
- 8.3 Boston Scientific
- 8.3.1 Boston Scientific Company Information
- 8.3.2 Boston Scientific Business Overview
- 8.3.3 Boston Scientific Embolization Microsphere Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Boston Scientific Embolization Microsphere Product Portfolio
- 8.3.5 Boston Scientific Recent Developments
- 8.4 Sirtex Medical
- 8.4.1 Sirtex Medical Company Information
- 8.4.2 Sirtex Medical Business Overview
- 8.4.3 Sirtex Medical Embolization Microsphere Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Sirtex Medical Embolization Microsphere Product Portfolio
- 8.4.5 Sirtex Medical Recent Developments
- 8.5 Merit Medical
- 8.5.1 Merit Medical Company Information
- 8.5.2 Merit Medical Business Overview
- 8.5.3 Merit Medical Embolization Microsphere Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Merit Medical Embolization Microsphere Product Portfolio
- 8.5.5 Merit Medical Recent Developments
- 8.6 INterface BIOmaterials B.V.
- 8.6.1 INterface BIOmaterials B.V. Company Information
- 8.6.2 INterface BIOmaterials B.V. Business Overview
- 8.6.3 INterface BIOmaterials B.V. Embolization Microsphere Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 INterface BIOmaterials B.V. Embolization Microsphere Product Portfolio
- 8.6.5 INterface BIOmaterials B.V. Recent Developments
- 8.7 HENGRUI Medical
- 8.7.1 HENGRUI Medical Company Information
- 8.7.2 HENGRUI Medical Business Overview
- 8.7.3 HENGRUI Medical Embolization Microsphere Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 HENGRUI Medical Embolization Microsphere Product Portfolio
- 8.7.5 HENGRUI Medical Recent Developments
- 8.8 BTG Medical
- 8.8.1 BTG Medical Company Information
- 8.8.2 BTG Medical Business Overview
- 8.8.3 BTG Medical Embolization Microsphere Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 BTG Medical Embolization Microsphere Product Portfolio
- 8.8.5 BTG Medical Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Embolization Microsphere Value Chain Analysis
- 9.1.1 Embolization Microsphere Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Embolization Microsphere Production Mode & Process
- 9.2 Embolization Microsphere Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Embolization Microsphere Distributors
- 9.2.3 Embolization Microsphere Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst